Practical Strategies for Pharmaceutical Companies in U.S. Patent Litigation

Goodwin Procter, along with Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA) and Taiwan Generic Pharmaceutical Association (TGPA), will host "Practical Strategies for Pharmaceutical Companies in U.S. Patent Litigation," a complimentary half-day seminar. Key topics to be discussed include: recent developments in pharmaceutical patent litigation; strategies for challenging pharmaceutical patents at the PTAB and an update on biosimilars litigation. Goodwin Procter speakers include Emily Rapalino and Huiya Wu.